INTS6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.506400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.864400E-01
Normal-vs-Stage2
9.170600E-01
Normal-vs-Stage3
2.633800E-02
Normal-vs-Stage4
2.177400E-01
Stage1-vs-Stage2
3.020800E-01
Stage1-vs-Stage3
1.142360E-02
Stage1-vs-Stage4
9.326400E-01
Stage2-vs-Stage3
6.044700E-04
Stage2-vs-Stage4
3.524400E-01
Stage3-vs-Stage4
1.557670E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.545800E-01
Normal-vs-AfricanAmerican
6.258000E-01
Normal-vs-Asian
5.023800E-01
Caucasian-vs-AfricanAmerican
3.957400E-01
Caucasian-vs-Asian
8.930300E-02
AfricanAmerican-vs-Asian
1.661950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.119600E-01
Normal-vs-Female
9.920400E-01
Male-vs-Female
7.025600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.055800E-01
Normal-vs-Age(41-60Yrs)
6.879000E-01
Normal-vs-Age(61-80Yrs)
9.011000E-01
Normal-vs-Age(81-100Yrs)
9.577600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.067800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.602800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.467400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.228400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.000400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.956200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.499800E-01
Normal-vs-Daily Drinker
6.082200E-01
Normal-vs-Weekly Drinker
6.292600E-01
Normal-vs-Occasional Drinker
7.352200E-01
Normal-vs-Social Drinker
8.905600E-01
Non Drinker-vs-Daily Drinker
4.835600E-01
Non Drinker-vs-Weekly Drinker
5.481000E-01
Non Drinker-vs-Occasional Drinker
3.060800E-01
Non Drinker-vs-Social Drinker
5.396000E-01
Daily Drinker-vs-Weekly Drinker
9.995000E-01
Daily Drinker-vs-Occasional Drinker
1.112630E-01
Daily Drinker-vs-Social Drinker
2.428800E-01
Weekly Drinker-vs-Occasional Drinker
1.588750E-01
Weekly Drinker-vs-Social Drinker
3.009000E-01
Occasional Drinker-vs-Social Drinker
7.481000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.123600E-02
Normal-vs-Grade 2
2.721600E-03
Normal-vs-Grade 3
2.341300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.050600E-01
Grade 1-vs-Grade 3
1.641780E-01
Grade 1-vs-Grade 4
3.123600E-02
Grade 2-vs-Grade 3
3.253600E-01
Grade 2-vs-Grade 4
2.721600E-03
Grade 3-vs-Grade 4
2.341300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.775400E-01
Normal-vs-NonDiabetic
9.205400E-01
Diabetic-vs-NonDiabetic
3.736600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.642600E-01
Normal-vs-NoPancreatitis
9.201400E-01
Pancreatitis-vs-NoPancreatitis
6.489400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.701800E-01
Normal-vs-N1
9.123600E-01
N0-vs-N1
8.036400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.417000E-01
Normal-vs-TP53-NonMutant
9.174400E-01
TP53-Mutant-vs-TP53-NonMutant
4.371200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
